October 26, 2016 11:36 AM ET


Company Overview of Moderna Therapeutics, Inc.

Company Overview

Moderna Therapeutics, Inc. develops messenger RNA therapeutics. The company provides in vivo drug modality that produces human proteins or antibodies inside patient cells. It also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. The company focuses on disease areas, such as inherited genetic disorders, hemophilic and blood factors, and oncology. Moderna Therapeutics, Inc. has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals, Inc.; and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck. The company was incorporated in 2009 and i...

200 Tech Square

Cambridge, MA 02139

United States

Founded in 2009





Key Executives for Moderna Therapeutics, Inc.

Founding Chief Executive Officer and Director
Age: 43
Co-Founder, Chairman and Member of Technology Advisory Board
Age: 53
Chief Financial Officer
Age: 42
Senior Vice President of Technology Strategy
Age: 57
Compensation as of Fiscal Year 2016.

Moderna Therapeutics, Inc. Key Developments

Moderna Therapeutics Appoints Annie Seibold Drapeau as Chief Human Resources Officer

Moderna Therapeutics announced the appointment of Annie Seibold Drapeau as chief human resources officer. In her new role, Ms. Drapeau will lead Moderna's talent and organizational strategy to support its continued growth and advancement of its mRNA drug pipeline. She currently serves as an Operating Partner at Bain Capital Private Equity, where she partners with companies across the private equity portfolio on a range of talent and organizational capability initiatives. Ms. Drapeau will join Moderna in late October and be a member of the company's executive committee, reporting to Moderna CEO Stphane Bancel. Prior to joining Bain Capital Private Equity, Ms. Drapeau served as Executive Vice President, Strategy and Talent at Iron Mountain, a $3 billion data storage and protection business with nearly 20,000 employees worldwide.

Moderna Therapeutics, Inc. Presents at Leerink Partners Rare Disease and Immuno-Oncology Roundtable Series, Sep-28-2016 01:05 PM

Moderna Therapeutics, Inc. Presents at Leerink Partners Rare Disease and Immuno-Oncology Roundtable Series, Sep-28-2016 01:05 PM. Venue: The Lotte New York Palace Hotel, New York, New York, United States.

Moderna Therapeutics to Build Fully Integrated GMP mRNA Clinical Manufacturing Facility in Norwood, Massachusetts

Moderna Therapeutics announced that it has signed a long-term lease (15 years plus renewal options) to build a Good Manufacturing Practices (GMP) clinical manufacturing facility in Norwood, Massachusetts. Moderna is committed to developing a broad array of medicines leveraging its leading mRNA platform, and to delivering on the promise of mRNA science for patients as quickly as possible. To support and manage this anticipated breadth of clinical studies, Moderna’s 200,000 square foot Norwood facility will enable the manufacture, quality, control and supply of clinical grade mRNA therapies and vaccines for Good Laboratory Practices (GLP) toxicology studies as well as Phase 1 and Phase 2 clinical studies. At the site, Moderna will carry out all manufacturing activities "from raw material production to active pharmaceutical ingredients (APIs), formulation, filling and finish. Moderna will begin initial build-out of the new facility in October 2016. The company plans to open the facility by early 2018.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Private Placement
August 10, 2016
Private Placement
July 6, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Moderna Therapeutics, Inc., please visit www.modernatx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.